Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Goodwill & Intangibles: 2020-2024

Historic Goodwill & Intangibles for Mereo BioPharma Group (MREO) over the last 4 years, with Dec 2024 value amounting to $643,000.

  • Mereo BioPharma Group's Goodwill & Intangibles fell 19.52% to $643,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $643,000, marking a year-over-year decrease of 19.52%. This contributed to the annual value of $643,000 for FY2024, which is 40.96% down from last year.
  • Per Mereo BioPharma Group's latest filing, its Goodwill & Intangibles stood at $643,000 for FY2024, which was down 40.96% from $1.1 million recorded in FY2023.
  • Mereo BioPharma Group's 5-year Goodwill & Intangibles high stood at $42.4 million for FY2020, and its period low was $643,000 during FY2024.
  • Its 2-year average for Goodwill & Intangibles is $866,000, with a median of $866,000 in 2023.
  • Data for Mereo BioPharma Group's Goodwill & Intangibles shows a maximum YoY crashed of 40.96% (in 2024) over the last 5 years.
  • Yearly analysis of 4 years shows Mereo BioPharma Group's Goodwill & Intangibles stood at $42.4 million in 2020, then dropped by 21.87% to $33.1 million in 2021, then reached $1.1 million in 2023, then plummeted by 40.96% to $643,000 in 2024.